 "Kumar Gaurav")
Kumar Gaurav
Kumar Gaurav
Kumar Gaurav is a business journalist driven by a profound passion for the economy, culture, and human rights. He covers market movements, IPOs, regulatory updates, and major developments in equity markets. Having earned a Master's degree in Journalism from the University of Delhi's Delhi School of Journalism, Kumar previously worked with ET Now and Financial Express, focusing on primary and secondary markets. His dedication lies in uncovering the connections between the markets and the human experience, offering a nuanced perspective on the world of business.
Kumar Gaurav is a business journalist driven by a profound passion for the economy, culture, and human rights. He covers market movements, IPOs, regulatory updates, and major developments in equity markets. Having earned a Master's degree in Journalism from the University of Delhi's Delhi School of Journalism, Kumar previously worked with ET Now and Financial Express, focusing on primary and secondary markets. His dedication lies in uncovering the connections between the markets and the human experience, offering a nuanced perspective on the world of business.
Page 9 - Kumar Gaurav
Q2FY26 results in line; Aurobindo Pharma could gain 25%, says Nuvama
According to Nuvama, Aurobindo's Q2FY26 revenue and Ebitda were ahead of consensus estimates by 2 per cent and 1 per cent, respectively, though PAT missed expectations by about 5 per cent
 "Q2FY26 results in line; Aurobindo Pharma could gain 25%, says Nuvama")
MFs near parity with FIIs as ownership gap hits record low: Prime Database
The share of FIIs declined further to a 13-year low of 16.71 per cent as on September 30, 2025 (down from 17.05 per cent on June 30, 2025), while MF holdings rose to an all-time high of 10.93 per cent
 "MFs near parity with FIIs as ownership gap hits record low: Prime Database")
Motilal Oswal gives 'Buy' to Waaree Energies, calls it a sector bellwether
With operational cell/module capacity of 5.4 GW/16.1 GW in India, WEL, analysts believe, towers domestic competitors and enjoys a formidable India capacity market share of 21.6 per cent/13.3 per cent
 "Motilal Oswal gives 'Buy' to Waaree Energies, calls it a sector bellwether")
Lenskart IPO allotment likely today; here's how to check status, latest GMP
Once the allotment is finalised, applicants can verify their allotment status online through the official websites of the BSE, NSE, or MUFG Intime India, the registrar to the issue
 "Lenskart IPO allotment likely today; here's how to check status, latest GMP")
Groww IPO: Justified valuation or time to chase better-valued rivals?
While Groww IPO attracts moderate interest, analysts debate if listed peers offer better value for money
 "Groww IPO: Justified valuation or time to chase better-valued rivals?")
Ajanta Pharma offers growth potential amid US generic challenges: Nuvama
With larger generic companies facing growth challenges in the US in FY27E, Ajanta Pharma, analysts believe, offers a strong investment opportunity, driven by its branded market growth
 "Ajanta Pharma offers growth potential amid US generic challenges: Nuvama")
Tata Motors demerger: Key things every investors should know before listing
As investors await the D-Street debut of the demerged entity, here are the key details they should know
 "Tata Motors demerger: Key things every investors should know before listing")
Lenskart warns: LASIK, SMILE may rattle India's $17-billion eyewear market
The company launched its initial public offering (IPO) on Friday, October 31, aiming to raise ₹7,278.02 crore from primary markets
 "Lenskart warns: LASIK, SMILE may rattle India's $17-billion eyewear market")
Analysts retain 'Buy' on BEL amid strong orders, margin growth, tech thrust
Nuvama Institutional Equities and Choice Institutional Equities have maintained their 'Buy' ratings on the Bharat after the company reported an 18 per cent rise in net profit to ₹1,286 crore in Q2FY26
 "Analysts retain 'Buy' on BEL amid strong orders, margin growth, tech thrust")
'Market coupling' poses threat to IEX, says Nuvama; assigns 'Reduce' tag
Analysts noted that while IEX benefits from RTM growth amid subdued power demand, long-term risks of power deficits could push up spot prices, potentially lowering spot volumes
 "'Market coupling' poses threat to IEX, says Nuvama; assigns 'Reduce' tag")
Q2 earnings spark mixed analyst views on Mahanagar Gas; buy, sell, or hold
MGL's Q2FY26 results, analysts said, highlight near-term margin pressures, even as volume growth remains steady.
 "Q2 earnings spark mixed analyst views on Mahanagar Gas; buy, sell, or hold")
United Spirits Q2 profit soars 36%; here's what investors should do next
ICICI Securities has maintained its Add rating on the stock with a revised target price of ₹1,550 per share (previously ₹1,450), while Nuvama has retained its Buy rating with a target price of ₹1710
 "United Spirits Q2 profit soars 36%; here's what investors should do next")
Stocks to Watch today: ITC, RIL, TCS, Vedanta, Hyundai Motor India, Swiggy
Stocks to Watch Today, October 31, 2025: RIL, Hyundai Motor India, TCS, Bharat Electronics, ITC, Swiggy, United Spirits, and Sunteck Realty are among the top stocks to watch today
 "Stocks to Watch today: ITC, RIL, TCS, Vedanta, Hyundai Motor India, Swiggy")
Lenkart IPO: Brokerages upbeat; GMP stays firm; should you park your money?
Lenkart IPO Open: Adding to the positive sentiment, early trends in the grey market indicate a favorable start for the public offering
 "Lenkart IPO: Brokerages upbeat; GMP stays firm; should you park your money?")
L&T's growth story intact, say analysts after Q2 show; buy, sell, or hold?
Nuvama Institutional Equities and Motilal Oswal Financial Services (MOFSL) have retained their Buy ratings on L&T, signaling confidence in the company's medium-term growth prospects.
 "L&T's growth story intact, say analysts after Q2 show; buy, sell, or hold?")
Stocks to Watch today: Coal India, L&T, Wipro, Bharti Airtel, Ola Electric
Stocks to Watch Today, October 30, 2025: Wipro, L&T, Coal India, United Breweries, Ola Electric, ITC, Swiggy, Mankind Pharma, and Dr Reddy's Labs are among the top stocks to watch today
 "Stocks to Watch today: Coal India, L&T, Wipro, Bharti Airtel, Ola Electric")
JM Financial initiates coverage on Endurance Tech with a 'Buy'; here's why
At the current market price, the brokerage sees around 17 per cent upside for the stock and has set a price target of ₹3,435, based on a 32x FY28E P/E.
 "JM Financial initiates coverage on Endurance Tech with a 'Buy'; here's why")
GAIL's valuations attractive, says Motilal Oswal; tariff hike key catalyst
According to MOFSL, GAIL's valuations have corrected sharply from their September 2024 highs, with the stock now trading close to historical averages at 1.1x one-year forward core P/B
 "GAIL's valuations attractive, says Motilal Oswal; tariff hike key catalyst")
Analysts split on Shree Cement post Q2 show: should you buy, sell, or hold?
While Nuvama Institutional Equities has reiterated its 'Hold' rating on Shree Cement, Choice Institutional Equities has maintained a 'Sell' call, citing expensive valuations and limited upside
 "Analysts split on Shree Cement post Q2 show: should you buy, sell, or hold?")
Stocks to Watch today: Adani Green, Shree Cement, Mazagon, Oil India, Hudco
Stocks to Watch Today, October 29, 2025: Tata Capital, TVS Motor Company, Adani Green Energy, Larsen & Toubro, and Oil India are among the top stocks to watch during today's trading session
 "Stocks to Watch today: Adani Green, Shree Cement, Mazagon, Oil India, Hudco")